Quick Answer
Omada Health, Inc. reported Total Revenue of $260.21 million for fiscal year 2025.
Omada Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $260.21M +53.2% |
$169.80M +38.3% |
$122.78M | — |
| Revenue (ASC 606) | $260.21M +53.2% |
$169.80M +38.3% |
$122.78M | — |
| Net Income | -$12.78M +72.9% |
-$47.14M +30.2% |
-$67.51M | — |
| Diluted EPS | -$0.35 +94.3% |
-$6.11 +35.8% |
-$9.52 | — |
| Total Assets | $305.41M +102.4% |
$150.89M | — | — |
| Cash and Equivalents | $222.04M +190.7% |
$76.39M | — | — |
| Long-Term Debt | $0.00 -100.0% |
$29.77M | — | — |
| Stockholders Equity | $229.68M +159.7% |
-$384.40M -9.8% |
-$350.11M -19.4% |
-$293.17M |
| R&D Expense | $40.68M +13.3% |
$35.92M +6.5% |
$33.74M | — |
| Operating Income | -$11.97M +72.6% |
-$43.65M +33.9% |
-$66.00M | — |
| Gross Profit | $170.94M +66.2% |
$102.88M +47.0% |
$69.97M | — |
| Shares Outstanding | 58.43M +616.3% |
8.16M | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $68.03M | +49.5% | +10.9% |
| Revenue (ASC 606) | September 30, 2025 | $68.03M | +49.5% | +10.9% |
| Net Income | September 30, 2025 | -$3.18M | +65.6% | +40.2% |
| Diluted EPS | September 30, 2025 | -$0.06 | +94.9% | +75.0% |
| Total Assets | September 30, 2025 | $287.47M | — | -5.1% |
| Cash and Equivalents | September 30, 2025 | $198.63M | — | -11.0% |
| Long-Term Debt | September 30, 2025 | $0.00 | — | -100.0% |
| Stockholders Equity | September 30, 2025 | $217.35M | +157.2% | +1.5% |
| R&D Expense | September 30, 2025 | $10.30M | +16.4% | +2.8% |
| Operating Income | September 30, 2025 | -$2.51M | +70.5% | +42.2% |
| Gross Profit | September 30, 2025 | $45.07M | +57.8% | +11.8% |
| Shares Outstanding | September 30, 2025 | 57.89M | — | +1.0% |
- Omada Health, Inc. reported Total Revenue of $260.21 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +53.2% in Total Revenue compared to the prior fiscal year.
- Omada Health, Inc. reported Revenue (ASC 606) of $260.21 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +53.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Omada Health, Inc. reported Net Income of -$12.78 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +72.9% in Net Income compared to the prior fiscal year.
- Omada Health, Inc. reported Diluted EPS of $0.35 per share (loss) for fiscal year 2025.
- Omada Health, Inc. showed an increase of +94.3% in Diluted EPS compared to the prior fiscal year.
- Omada Health, Inc. reported Total Assets of $305.41 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +102.4% in Total Assets compared to the prior fiscal year.
- Omada Health, Inc. reported Cash and Equivalents of $222.04 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +190.7% in Cash and Equivalents compared to the prior fiscal year.
- Omada Health, Inc. reported Long-Term Debt of $0.00 for fiscal year 2025.
- Omada Health, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Omada Health, Inc. reported Stockholders Equity of $229.68 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +159.7% in Stockholders Equity compared to the prior fiscal year.
- Omada Health, Inc. reported R&D Expense of $40.68 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +13.3% in R&D Expense compared to the prior fiscal year.
- Omada Health, Inc. reported Operating Income of -$11.97 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +72.6% in Operating Income compared to the prior fiscal year.
- Omada Health, Inc. reported Gross Profit of $170.94 million for fiscal year 2025.
- Omada Health, Inc. showed an increase of +66.2% in Gross Profit compared to the prior fiscal year.
- Omada Health, Inc. reported Shares Outstanding of 58.43 million shares for fiscal year 2025.
- Omada Health, Inc. showed an increase of +616.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: